Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital FVII Deficiency”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT01312636
What this trial is testing

Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency

Who this might be right for
Congenital Bleeding DisorderCongenital FVII Deficiency
Novo Nordisk A/S 36
Testing effectiveness (Phase 2)Looking for participantsNCT07347249
What this trial is testing

A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency

Who this might be right for
Congenital Factor VII Deficiency
Hemab ApS 18
Early research (Phase 1)Study completedNCT01561417
What this trial is testing

Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

Who this might be right for
Acquired Bleeding DisorderAcquired HaemophiliaCongenital Bleeding Disorder+5 more
Novo Nordisk A/S 28
Not applicableStudy completedNCT01779921
What this trial is testing

Treatment of Congenital Factor VII Deficiency

Who this might be right for
Congenital Bleeding DisorderCongenital FVII Deficiency
Novo Nordisk A/S 163
Not applicableStudy completedNCT00697320
What this trial is testing

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Who this might be right for
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's Disease+2 more
Novo Nordisk A/S 64